Laennec 50A

Laennec is a human placenta injectable solution designed to support liver function in individuals suffering from chronic hepatic disease. Laennec uses advanced technologies to preserve and deliver growth factors, cytokines (small proteins in the immune system), and active peptides. These support cellular regeneration and immune modulation with specific applications in liver tissue repair.

Laennec is approved as an ethical drug and is manufactured under Japan Bio Products. Due to its main ingredient originating from the human placenta, it is regulated and intended for use only under the supervision of licensed healthcare professionals.

Key Features:

Effective

• Promotes liver cell regeneration via HGF and other active proteins
• Improves levels of GOT and GPT in chronic liver disease
• Clinically proven through pharmacological studies
• Eliminates insomnia and improves physical fatigue
• Boosts the immune system
• Stimulates the regeneration of liver cells
• Drastically improves skin elasticity
• Boosts the immune defences
• Improves circulation

Safe

• Rigorous viral and bacterial screening
• Heat-treated to inactivate pathogens
• No confirmed cases of viral transmission

Active

• Contains naturally derived human growth factors
• Stimulates DNA synthesis
• Supports anti-inflammatory effects and anti-fatty liver

Ingredients:

• Water-soluble human placenta hydrolysate

Water-soluble human placenta hydrolysate is a biological extract derived from fully formed human placentas. This contains a concentrated blend of amino acids, peptides, enzymes, nucleic acids, and other active substances that support cellular regeneration, immune function, and skin revitalization.

• A combination of water-soluble cytokines – molecules involved in strengthening immunity and relieving inflammation.
• Growth factors stimulate cell renewal, collagen synthesis, restoration of nerve fibers, etc.
• Low molecular weight proteins and amino acids.
• Vitamins PP, C, B1, B2, B3, and D.
• Organic acids stimulate the synthesis of protein molecules.

Administration:

Laennec therapy can be carried out by different methods:

• intramuscularly in 4 ml for 21 days every other day
• intravenously with a dropper of 8-10 ml 2 times a week (the course is 10 procedures)
• mesotherapy method
• according to the method of pharmacopuncture, in which Laennec is introduced in microdoses into individual biologically active points – in this case 10-14 procedures are shown, 2-3 per week.

**Specifications: **

-Volume: 2ml per ampoule (50 ampoules per pack)

-Storage: Keep sealed and stored at room temperature

-Country of Manufacture: Japan

-Manufacturer: Japan Bio Products Co., Ltd.

Laennec should be applied as directed by a professional. The standard dosage is 2 mL by intramuscular or subcutaneous injection, once daily. This may be increased to 2-3 times daily depending on the patient’s symptoms. Injection site rotation is recommended to avoid tissue damage.

If any symptoms such as rash, fever, or persistent swelling occur, discontinue use and consult a medical provider immediately.

Due to its origin, patients must be informed of potential infection risks, however minimal, by their doctor. This product is not recommended for patients with known allergies to human tissue derivatives, children, infants, newborns, and individuals with a history of hypersensitivity to placenta-derived substances. Elderly patients should administer Laennec with caution due to possible reduced organ function.

Warning: Consult with a doctor in advance before using this product. If you have a particular medical condition, always consult with your doctor before using cosmetic treatments.

Note: Like all products, Laennec may have contradictions as products do not work the same for every individual. Fillerhouse is not responsible for any unwanted effects patients may experience when using this product.

Conclusion: Laennec is an ethically produced injectable used for the treatment of chronic liver conditions. Backed by extensive clinical research, it supports liver regeneration and immune modulation through the power of placental bioactive compounds. If administered correctly, Laennec represents an advanced biological solution for managing hepatic decline.